Boston Scientific (BSX) Shares Outstanding (2009 - 2026)

Boston Scientific has disclosed Shares Outstanding (Entity) across 18 years of filings, most recently posting $1.4 billion for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) fell 2.19% year-over-year to $1.4 billion; the TTM figure through Jun 2026 stood at $1.4 billion (down 2.19% YoY), while the FY2025 annual figure was $1.5 billion, up 0.55% from the prior year.
• Shares Outstanding (Entity) came in at $1.4 billion for Q2 2026 at Boston Scientific, down from $1.5 billion in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $1.5 billion in Q1 2026 to a low of $1.4 billion in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $1.5 billion, with a median of $1.5 billion recorded in 2023.
• Year-over-year, Shares Outstanding (Entity) rose 2.28% in 2023 and retreated 2.19% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $1.4 billion in 2022, then rose by 2.25% to $1.5 billion in 2023, then climbed by 0.59% to $1.5 billion in 2024, then advanced by 0.55% to $1.5 billion in 2025, then decreased by 2.34% to $1.4 billion in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $1.4 billion in Q2 2026, $1.5 billion in Q1 2026, and $1.5 billion in Q4 2025.